Avalo Therapeutics's book value per share for the quarter that ended in Mar. 2024 was $-131.02.
During the past 3 years, the average Book Value Per Share Growth Rate was -21.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Avalo Therapeutics was 332.60% per year. The lowest was -88.10% per year. And the median was -51.30% per year.
During the past 11 years, the highest P/B Ratio of Avalo Therapeutics was 2524.68. The lowest was 0.46. And the median was 12.01.
Avalo Therapeutics Book Value per Share Historical Data
The historical data trend for Avalo Therapeutics's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Avalo Therapeutics's Book Value per Share
For the Biotechnology subindustry, Avalo Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avalo Therapeutics's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Avalo Therapeutics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Avalo Therapeutics's PB Ratio falls into.
Avalo Therapeutics Book Value per Share Calculation
Avalo Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Avalo Therapeutics (NAS:AVTX) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Avalo Therapeutics Book Value per Share Related Terms
Thank you for viewing the detailed overview of Avalo Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Avalo Therapeutics (Avalo Therapeutics) Business Description
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AVTX has been successfully added to your 